Trojan Horse Delivery of 4,4′‐Dimethoxychalcone for Parkinsonian Neuroprotection-Reference-Cited by-同舟云学术

Trojan Horse Delivery of 4,4′‐Dimethoxychalcone for Parkinsonian Neuroprotection

Published:2021-03-03 Issue:9 Volume:8 Page:2004555
ISSN:2198-3844
Container-title:Advanced Science
language:en
Short-container-title:Adv. Sci.

Author:

Zhang Wenlong¹,Chen Huaqing²,Ding Liuyan¹,Gong Junwei³,Zhang Mengran³,Guo Wenyuan¹,Xu Pingyi¹,Li Shiying²,Zhang Yunlong³^ORCID

Affiliation:

1. Department of Neurology The First Affiliated Hospital of Guangzhou Medical University Guangzhou 510120 China

2. Key Laboratory of Molecular Target & Clinical Pharmacology and the State Key Laboratory of Respiratory Disease School of Pharmaceutical Sciences & The Fifth Affiliated Hospital Guangzhou Medical University Guangzhou 511436 China

3. Key Laboratory of Neurological Function and Health School of Basic Medical Sciences Guangzhou Medical University Guangzhou 511436 China

Funder

National Natural Science Foundation of China

China Association for Science and Technology

Natural Science Foundation of Guangdong Province

Guangzhou Medical University

Publisher

Wiley

Subject

General Physics and Astronomy,General Engineering,Biochemistry, Genetics and Molecular Biology (miscellaneous),General Materials Science,General Chemical Engineering,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/advs.202004555

Reference69 articles.

1. Parkinson disease

2. Diagnosis and Treatment of Parkinson Disease

3. The prevalence of Parkinson's disease: A systematic review and meta-analysis

4. The epidemiology of Parkinson's disease: risk factors and prevention

5. Parkinson's Disease

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Highly BBB-permeable nanomedicine reverses neuroapoptosis and neuroinflammation to treat Alzheimer's disease;Biomaterials;2025-01

2. Nanotherapeutic Approaches of Interleukin‐3 to Clear the α‐Synuclein Pathology in Mouse Models of Parkinson's Disease;Advanced Science;2024-09-03

3. Harnessing nanomedicine for modulating microglial states in the central nervous system disorders: Challenges and opportunities;Biomedicine & Pharmacotherapy;2024-08

4. FNDC5 prevents oxidative stress and neuronal apoptosis after traumatic brain injury through SIRT3-dependent regulation of mitochondrial quality control;Cell Death & Disease;2024-05-27

5. Usp14 deficiency removes α-synuclein by regulating S100A8/A9 in Parkinson’s disease;Cellular and Molecular Life Sciences;2024-05-23